Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • The group's high margin levels account for strong profits.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The tendency within the weekly time frame is positive above the technical support level at 88.71 USD
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 114.42.
  • The group usually releases earnings worse than estimated.
  • The company's enterprise value to sales, at 6.07 times its current sales, is high.
  • The company benefits from high valuations in earnings multiples.
  • The company is not the most generous with respect to shareholders' compensation.
Ratings chart
Sector Medical Equipment, Supplies & Distribution - NEC
1st jan.Capitalisation (M$)Investor Rating
ABBOTT LABORATORIES25.80%193 666
MEDTRONIC PLC-2.19%149 189
BECTON, DICKINSON AND COMPA..-15.99%66 229
HOYA CORPORATION25.50%44 928
BAXTER INTERNATIONAL INC.-9.39%38 705
ALIGN TECHNOLOGY, INC.70.79%37 579
SARTORIUS STEDIM BIOTECH101.08%32 342
DEXCOM, INC.46.79%30 834
ZIMMER BIOMET HOLDINGS-2.30%30 250
TERUMO CORPORATION7.93%29 380
WEST PHARMACEUTICAL SERVICE..89.40%21 049
AMERISOURCEBERGEN CORPORATI..18.16%20 523
SYSMEX CORPORATION37.27%20 318
STERIS PLC24.06%16 728
BIO-RAD LABORATORIES, INC.49.98%16 566
AVANTOR, INC.42.70%14 979
More Results
Financials (USD)
Sales 2020 33 873 M - -
Net income 2020 4 415 M - -
Net Debt 2020 11 794 M - -
P/E ratio 2020 44,6x
Yield 2020 1,32%
Capitalization 194 B 194 B -
EV / Sales 2020 6,07x
EV / Sales 2021 5,28x
Nbr of Employees 107 000
Free-Float 88,9%
Upcoming event on ABBOTT LABORATORIES
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes